BridgeBio Pharma (BBIO) PT Raised to $130 at Evercore ISI

May 8, 2026 5:06 AM

Evercore ISI analyst Cory Kasimov raised the price target on BridgeBio Pharma (NASDAQ: BBIO) to $130.00 (from $125.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found